Education
About Us
Working with TipRanks
Follow Us
Precipio Inc (PRPO)
NASDAQ:PRPO
Earnings Data
Report Date
Aug 25, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
―Last Year’s EPS
-0.83Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 14, 2025
|% Change Since: 20.78%
|Next Earnings Date:Aug 25, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted strong year-over-year revenue growth, improved margins, and significant operational efficiency gains. However, these positives were somewhat offset by a quarter-over-quarter revenue decline, delays in product division revenue realization, and initial uncertainty regarding FDA regulations. Despite these challenges, the overall sentiment remains cautiously optimistic, with expectations of continued growth and positive cash flow in the coming quarters.Company Guidance
In the first quarter of 2025, Precipio reported strong financial performance with a 43% year-over-year revenue increase to $4.9 million, although it experienced a 9.5% decline from the previous quarter. The company improved its adjusted EBITDA by 92%, reducing losses to $108,000, and cut cash usage by 93% compared to the same period last year. Pathology Services saw a 46% increase in test volume and a 53% revenue growth, while gross margins rose significantly from 24% to 42%. Operating expenses dropped by 30%, from 87% to 61% of revenue, and the company maintained flat operating expenses at approximately $3 million per quarter. Precipio also achieved MolDx approval for its next-generation sequencing tests, potentially adding approximately $250,000 in quarterly revenue. The Product division improved gross margins from 37% to 51% year-over-year and is expected to drive future growth, particularly following the overturning of the FDA ruling on laboratory tests. Overall, Precipio aims to achieve positive operating cash flow by Q2 or Q3 of 2025.Record Revenue Growth
Q1 2025 revenues were $4.9 million, marking a 43% year-over-year increase driven by sustained demand in Pathology Services.
Improved Margins and Operational Efficiency
Pathology gross margins increased from 24% to 42% year-over-year, and operating expenses as a percent of revenue dropped from 87% to 61%.
Significant EBITDA Improvement
Adjusted EBITDA improved by 92%, with a $108,000 loss in Q1 compared to a $1.4 million loss in the same period last year.
MolDx Approval
Received MolDx approval for next-generation sequencing testing, potentially increasing revenue by approximately $250,000 per quarter.
Product Division Progress
Gross margins for the Product division improved from 37% to 51% year-over-year, with new customers and product launches contributing to growth.
Positive Non-Recurring Impacts
Received over $400,000 in COVID relief funds and negotiated a $130,000 write-off with Change Healthcare, positively impacting cash flow.
---
PRPO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PRPO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2025 | $6.93 | $7.15 | +3.17% |
Mar 31, 2025 | $6.27 | $5.65 | -9.89% |
Nov 18, 2024 | $6.19 | $6.08 | -1.78% |
Aug 19, 2024 | $5.41 | $5.82 | +7.58% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Precipio Inc (PRPO) report earnings?
Precipio Inc (PRPO) is schdueled to report earning on Aug 25, 2025, TBA Not Confirmed.
What is Precipio Inc (PRPO) earnings time?
Precipio Inc (PRPO) earnings time is at Aug 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRPO EPS forecast?
Currently, no data Available
---